Search results for

Craig has been a terrific James Bond, maybe even the best. But there's something a little too strained about the tragic emotional arc his character has carried with over the past several movies.

In a wide-ranging interview with NPR's Michel Martin, Rep. Adam Schiff discusses his regrets from President Donald Trump's first impeachment trial and his relationship with his GOP colleagues.

NPR's Scott Simon speaks with Howard Bryant of Meadowlark Media about the MLB playoffs, the NBA opening week, and about the NBA's recent list of the 75 greatest players of all time.

A new coronavirus variant — known as delta plus — has cropped up in the U.K. There's concern it could be more dangerous than the highly contagious delta variant. What does the science actually show?

Families of victims of the Sandy Hook Elementary massacre hope the $73 million settlement will put companies that insure gun-makers on notice that they could be on the hook for huge future payouts.

Rumors, misinformation and conspiracy theories were rampant on right-wing social media before verifiable information came out about the gunman who killed 21 people at a Texas elementary school.

Lionel Tate is back in jail for allegedly holding up a pizza deliveryman. The 18-year-old Florida youth was the youngest person to be sent to prison for life in U.S. history. At age 12, he was accused of murdering his 6-year-old neighbor and friend Tiffany Eunick when he claimed he was demonstrating wrestling moves. Ed Gordon talks with Sgt. DeLacy Davis, a mentor and one of several supporters that put together a "re-entry into society plan" for Tate.

The Federal Reserve wants to control inflation, and its number-one weapon is higher interest rates. The Fed is expected to announce another sharp jump in borrowing costs on Wednesday.

The White House has requested $22.5 billion in additional COVID relief, but 35 GOP senators warned they won't support more until Biden provides an accounting of trillions in prior relief spending.

NPR has learned that Pfizer and BioNtech have gathered additional data that the companies say strengthen their case for authorizing the COVID-19 vaccine for children younger than age five.